New strategies for treatment of ALK-rearranged non-small cell lung cancers. [electronic resource]
Producer: 20120427Description: 7213-8 p. digitalISSN:- 1557-3265
- Anaplastic Lymphoma Kinase
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- diagnosis
- Crizotinib
- Drug Resistance, Neoplasm -- genetics
- Humans
- Lung Neoplasms -- diagnosis
- Protein Kinase Inhibitors -- therapeutic use
- Pyrazoles -- therapeutic use
- Pyridines -- therapeutic use
- Receptor Protein-Tyrosine Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.